SAGAN PAUL
SEC CIK 1035440 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MRNA | Moderna | Dir | 312.0K | $1.00M | $708.5K | 4 | 2021-08-12 | 2025-03-03 |
Most active insiders at MRNA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Bancel Stephane | CEO, Dir | — | $28.72M |
| 2 | Hoge Stephen | Pres | — | $28.43M |
| 3 | Mock James M | CFO | — | $4.69M |
| 4 | Klinger Shannon Thyme | CLO | — | $1.39M |
| 5 | AFEYAN NOUBAR | Dir | — | $1.14M |
| 6 | Hussain Abbas | Dir | — | $278.9K |
| 7 | Horning Sandra | Dir | — | — |
| 8 | NABEL ELIZABETH G | Dir | — | — |
| 9 | Rubenstein David M. | Dir | — | — |
| 10 | Nader Francois | Dir | — | — |
SAGAN PAUL made no open-market trades at MRNA in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-03-04 | 2025-03-03 | MRNA | Moderna | SAGAN PAUL | Dir | P - Purchase | $31.76 | +31.6K | 312.0K | +11% | +$1.00M |
| D | 2022-05-02 | 2022-04-28 | MRNA | Moderna | SAGAN PAUL | Dir | M - OptEx | $0.00 | +703 | 703 | New | $0 |
| I | 2021-10-15 | 2021-10-13 | MRNA | Moderna | SAGAN PAUL | Dir | S - Sale | $314.90 | -2,250 | 15.0K | -13% | -$708.5K |
| I | 2021-08-13 | 2021-08-12 | MRNA | Moderna | SAGAN PAUL | Dir | G - Gift | — | -50.0K | 370.4K | -12% | — |
Purchase Sale Sale after option exercise All abbreviations